We developed a novel method to analyze CAR T cell effector function in a stereolithographically bioprinted 3D tumor model, and present proof-of-concept here using CAR T cells targeting one neuroblastoma target protein, L1CAM, and a neuroblastoma cell line. This evidence concerns the gene L1CAM and neoplasm.